Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Schering in-licenses human antibody for gastric cancer

Dec. 2, 1999

Biomira enters collaborative agreement, licenses two patents for cancer vaccine

Nov. 29, 1999

Preliminary survival data from single Maxamine site submitted to ASCO

Nov. 24, 1999

AAPS news: clinical pharmacokinetic analysis of B43-genistein in patients

Nov. 23, 1999

Novel prostate cancer therapy in development at Procyon detailed at international conference

Nov. 23, 1999

NY-ESO-1-derived peptides and their use in cancer therapy and diagnosis

Nov. 23, 1999

StressGen to codevelop HspE7 with NCI for HPV diseases

Nov. 17, 1999

First approval granted for Melacine melanoma therapeutic vaccine

Nov. 5, 1999

Maxamine in combination with IL-2 shows positive results in brain cancer model

Nov. 3, 1999

Celltech Chiroscience development partner files for FDA approval of AML treatment

Nov. 2, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...